Testicular Cancer Epidemiology Forecast 2025-2034

In the United States, around 9,729 new testicular cancer cases are estimated to be diagnosed in 2025, as per the American Cancer Society. Further, nearly 600 deaths are projected to occur in the country in 2025 due to testicular cancer. The average age of testicular cancer diagnosis is reported to be about 33 years.

Testicular Cancer Epidemiology Forecast Report Coverage

The “Testicular Cancer Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of testicular cancer. It projects the future incidence and prevalence rates of testicular cancer across various populations. The study covers age and type as major determinants of the testicular cancer-affected population. The report highlights patterns in the prevalence of testicular cancer over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of testicular cancer in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Testicular Cancer: Disease Overview

Testicular cancer occurs due to the formation of malignant cells in the testicles, a part of the male reproductive organ. This rare disease is most common in young and middle-aged men. A bump or lump on a testicle is the first sign of testicular cancer. The cancer has a successful cure rate if it is diagnosed and treated early. Men with undescended testicles (cryptorchidism) and a family history of testicular cancer have a higher risk of developing the disease.

Testicular Cancer: Treatment Overview

Depending on the type and stage of testicular cancer, treatment options include surgery, chemotherapy, and radiation therapy. Orchiectomy is a common surgical procedure performed to remove the affected testicle. Chemotherapy is preferred for non-seminomas or when the cancer has spread to other parts of the body. A combination of drugs, such as cisplatin, etoposide, and bleomycin, is the primary treatment regimen. Radiation therapy is more commonly used for seminomas, with the treatment usually localized to the pelvic or abdominal area.

Epidemiology

The testicular cancer epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for testicular cancer by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for testicular cancer and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• According to the American Cancer Society, around 1 in every 250 males are estimated to develop testicular cancer at some point in their life.
• Studies show that the average age of diagnosis for testicular cancer is around 33 years, with 8% of cases occurring in men older than 55 years and 6% of cases occurring in children and teens.
• As per Cancer Research UK, there were an estimated 2,376 cases of testicular cancer in the United Kingdom in 2017-2019, with about 65 deaths occurring due to the disease.
• In comparison to other races, Caucasian or white men have the highest prevalence of testis cancer in the United States.

Country-wise Testicular Cancer Epidemiology

The testicular cancer epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of testicular cancer varies significantly between countries due to differences in genetic factors (such as family history and conditions like undescended testicles (cryptorchidism)), lifestyle, diet, environmental exposures, and healthcare access. In the United States, about 10,000 men are estimated to develop testicular cancer annually.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Testicular Cancer based on several factors.
• The Testicular Cancer Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of the testicular cancer are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of testicular cancer epidemiology in the 8 major markets?
• What will be the total number of patients with testicular cancer across the 8 major markets during the forecast period?
• What was the country-wise prevalence of testicular cancer in the 8 major markets in the historical period?
• Which country will have the highest number of testicular cancer patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of testicular cancer during the forecast period of 2025-2034?
• What are the currently available treatments for testicular cancer?
• What are the disease risks, signs, symptoms, and unmet needs of testicular cancer?

This product will be delivered within 3-5 business days.